Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination：a meta-analysis

References

• Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365–1376.
   PubMed Web of Science ®Google Scholar
• Wharton M. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am. 1996;10(3):571–581.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Otsuka T, Okuno Y, et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288–1290.
   PubMed Web of Science ®Google Scholar
• Recommendations for the use of live attenuated varicella vaccine. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1995;95(5):791–796.
   PubMedGoogle Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352(5):450–458.
   PubMed Web of Science ®Google Scholar
• Renas, Blostein, Boulton. Outbreak of varicella among vaccinated children–Michigan, 2003. MMWR Morb Mortal Wkly Rep. 2004;53(18):389–392.
   PubMedGoogle Scholar
• Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006;117(6):e1070–7.
   PubMed Web of Science ®Google Scholar
• Seward JF, Zhang JX, Maupin TJ, et al. Contagiousness of varicella in vaccinated cases: a household contact study. Jama. 2004;292(6):704–708.
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23(2 suppl.):132–137.
   PubMed Web of Science ®Google Scholar
• Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(Rr–4):1–40.
   PubMedGoogle Scholar
• Koch-Institut R. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Stand: Juli 2009. Epidemiologisches Bull. 2009;30: 279–298.
   Google Scholar
• Rumke HC, Loch HP, Hoppenbrouwers K, et al. Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses. Vaccine. 2011;29(22):3842–3849.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Becker T, Gajdos V, et al. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age. Vaccine. 2012;30(20):3082–3089.
   PubMed Web of Science ®Google Scholar
• Mahamud A, Wiseman R, Grytdal S, et al. Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine. 2012;30(48):6935–6939.
   PubMed Web of Science ®Google Scholar
• Perella D, Wang C, Civen R, et al. Varicella vaccine effectiveness in preventing community transmission in the 2-dose era. Pediatrics. 2016; 137(4).
   PubMed Web of Science ®Google Scholar
• Gould PL, Leung J, Scott C, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients–Arkansas, 2006. Pediatr Infect Dis J. 2009;28(8):678–681.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312–315.
   PubMed Web of Science ®Google Scholar
• Wutzler P, Bonanni P, Burgess M, et al. Varicella vaccination - the global experience. Expert Rev Vaccines. 2017;16(8):833–843.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Baldo V, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11(1):63–71.
   PubMed Web of Science ®Google Scholar
• Garcia Cenoz M, Castilla J, Chamorro J, et al. Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill. 2013;18(32):20552.
   PubMedGoogle Scholar
• Vrabel M. Preferred reporting items for systematic reviews and meta-analyses. Oncol Nurs Forum. 2015;42(5):552–554.
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Wells GASB, O’Connell D, Peterson J, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. cited 2012 Jun 15.
   Google Scholar
• Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field further observations. Epidemiol Rev. 1988;10:212–241.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Ngai AL, Staehle BO, Kuter BJ, et al. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children. Pediatr Infect Dis J. 1996;15(1):49–54.
   PubMed Web of Science ®Google Scholar
• Prymula R, Bergsaker MR, Esposito S, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383(9925):1313–1324.
   PubMed Web of Science ®Google Scholar
• Nguyen MD, Perella D, Watson B, et al. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006. Pediatr Infect Dis J. 2010;29(8):685–689.
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28(3):686–691.
   PubMed Web of Science ®Google Scholar
• Pang H, Wang C, Jiang Y, et al. Comparison of varicella vaccine effectiveness during outbreak in a primary school. Chin J Biologicals. 2015;28(1):68–71.
   Google Scholar
• Romera-Guirado FJ, Molina-Salas Y, Perez-Martin JJ, et al. [Varicella vaccine effectiveness in schoolchildren in outbreaks in a semi-urban area]. An Pediatr (Barc). 2016;84(1):30–38.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wang XX, Su WC, et al. Effectiveness of varicella vaccine based on several varicella outbreaks in Guangdong Province. South China J Prev Med. 2016;42(2):129–133.
   Google Scholar
• Thomas CA, Shwe T, Bixler D, et al. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatr Infect Dis J. 2014;33(11):1164–1168.
   PubMed Web of Science ®Google Scholar
• Liese JG, Cohen C, Rack A, et al. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013;32(9):998–1004.
   PubMed Web of Science ®Google Scholar
• Cenoz MG, Martinez-Artola V, Guevara M, et al. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain. Hum Vaccin Immunother. 2013;9(5):1172–1176.
   PubMed Web of Science ®Google Scholar
• Shinefield H, Black S, Digilio L, et al. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children. Pediatr Infect Dis J. 2005;24(8):665–669.
   PubMed Web of Science ®Google Scholar
• Goh P, Lim FS, Han HH, et al. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age. Infection. 2007;35(5):326–333.
   PubMed Web of Science ®Google Scholar
• Schuster V, Otto W, Maurer L, et al. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Pediatr Infect Dis J. 2008;27(8):724–730.
   PubMed Web of Science ®Google Scholar
• Huang LM, Lee BW, Chan PC, et al. Immunogenicity and safety of combined measles-mumps-rubella-varicella vaccine using new measles and rubella working seeds in healthy children in Taiwan and Singapore: a phase II, randomized, double-blind trial. Hum Vaccin Immunother. 2013.
   Google Scholar
• Lalwani S, Chatterjee S, Balasubramanian S, et al. Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubellavaricella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial. BMJ Open. 2015.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741.
   PubMed Web of Science ®Google Scholar
• Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second varicella vaccine dose in children in Germany, 2009–2014. J Pediatr. 2016;173:202–206.e2.
   PubMedGoogle Scholar
• Bayer O, Heininger U, Heiligensetzer C, et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine. 2007;25(37–38):6655–6660.
   PubMed Web of Science ®Google Scholar
• Watson B, Boardman C, Laufer D, et al. Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine. Clin Infect Dis. 1995;20(2):316–319.
   PubMed Web of Science ®Google Scholar
• Vázquez M, Larussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. Jama. 2004;291(7):851.
   PubMed Web of Science ®Google Scholar
• Su JR, Leroy Z, Lewis PW, et al. Safety of second-dose single-antigen varicella vaccine. Pediatrics. 2017; 139(3):e20162536.
   PubMed Web of Science ®Google Scholar
• Czajka H, Schuster V, Zepp F, et al. A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile. Vaccine. 2009;27(47):6504–6511.
   PubMed Web of Science ®Google Scholar
• Kuter BJ, Brown M, Wiedmann RT, et al. Safety and immunogenicity of M-M-RII (combination measles-mumps-rubella vaccine) in clinical trials of healthy children conducted between 1988 and 2009. Pediatr Infect Dis J. 2016;35(9):1011–1020.
   PubMed Web of Science ®Google Scholar
• LeBaron CW, Bi D, Sullivan BJ, et al. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine. Pediatrics. 2006;118(4):1422–1430.
   PubMed Web of Science ®Google Scholar
• Walter EB, Snyder MA, Clements DA, et al. Large injection site reactions after a second dose of varicella vaccine. Pediatr Infect Dis J. 2008;27(8):757–759.
   PubMed Web of Science ®Google Scholar